North America Point-of-Care Diagnostics Market - 2024-2033
The North America Point-of-Care Diagnostics Market was valued at US$ 6.74 billion in 2024 and is anticipated to reach US$ 13.25 billion by 2033, at a CAGR of 0.079 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the North America Point-of-Care Diagnostics Market.
This report delivers a comprehensive overview of the North America Point-of-Care Diagnostics Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding North America Point-of-Care Diagnostics Market. The North America Point-of-Care Diagnostics Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.
North America Point-of-Care Diagnostics Market Scope:
Key Players
This report delivers a comprehensive overview of the North America Point-of-Care Diagnostics Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding North America Point-of-Care Diagnostics Market. The North America Point-of-Care Diagnostics Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the North America Point-of-Care Diagnostics Market.
This report delivers a comprehensive overview of the North America Point-of-Care Diagnostics Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding North America Point-of-Care Diagnostics Market. The North America Point-of-Care Diagnostics Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.
North America Point-of-Care Diagnostics Market Scope:
Key Players
- BD
This report delivers a comprehensive overview of the North America Point-of-Care Diagnostics Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding North America Point-of-Care Diagnostics Market. The North America Point-of-Care Diagnostics Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
- Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
- South America (Colombia, Brazil, Argentina, Rest of South America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
- Increase Your Customer Base by 3X using our Partner Identification tool
- Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
- Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
- Prioritize partners by strategic fit rather than general capability.
- Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
- Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
- White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
- Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
- Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
- Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
1. MARKET INTRODUCTION AND SCOPE
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
3. MARKET HIGHLIGHTS AND STRATEGIC TAKEAWAYS
3.1. Key Trends and Future Projections
4. SNIPPET BY PRODUCT
4.1. Snippet by Technology
4.2. Snippet by Application
4.3. Snippet by End-User
5. DYNAMICS
5.1. Impacting Factors
5.1.1. Drivers
5.1.1.1. Rising Advancements in Point-of-Care Diagnostics
5.1.1.2. Rising Aging Population and Chronic Diseases in North America
5.1.1.3. XX
5.1.2. Restraints
5.1.2.1. Connectivity & Data Integration Issues
5.1.2.2. Competition from Alternative Diagnostic Technologies
5.1.2.3. XX
5.1.3. Opportunity
5.1.3.1. Expansion of Home-Based Testing
5.1.3.2. Advancements in Digital and Mobile Health Integration
5.1.4. Impact Analysis
6. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
6.1. Market Leaders and Pioneers
6.1.1. Emerging Pioneers and Prominent Players
6.1.2. Established Leaders with the Largest Marketing Brand
6.1.3. Market Leaders with Established Products
6.2. Latest Developments and Breakthroughs
6.3. North America Regulatory and Reimbursement Landscape
6.4. Porter’s Five Forces Analysis
6.5. Supply Chain Analysis
6.6. Patent Analysis
6.7. SWOT Analysis
6.8. Unmet Needs and Gaps
6.9. Recommended Strategies for Market Entry and Expansion
6.10. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
6.11. Pricing Analysis and Price Dynamics
7. POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
7.1.2. Market Attractiveness Index, By Product
7.2. Infectious Disease Testing Products*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Blood Glucose Products
7.4. Blood Gas & Electrolyte Products
7.5. Hematology Testing Products
7.6. Urinalysis Products
7.7. Pregnancy and Fertility Testing Products
7.8. Tumor/Cancer Profiling Products
7.9. Drug-of-Abuse Products
7.10. Others
8. POINT-OF-CARE DIAGNOSTICS MARKET, BY TECHNOLOGY
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
8.1.2. Market Attractiveness Index, By Technology
8.2. Lateral Flow Assays*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Immunoassays
8.4. Molecular Diagnostics
8.5. Microfluidics
8.6. Others
9. POINT-OF-CARE DIAGNOSTICS MARKET, BY APPLICATION
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Infectious Diseases*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Hematology
9.4. Cardiology
9.5. Endocrinology
9.6. Oncology
9.7. Drug Testing
9.8. Neurology
9.9. Others
10. POINT-OF-CARE DIAGNOSTICS MARKET, BY END-USER
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals & Clinics*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Diagnostic Laboratories
10.4. Ambulatory Surgery Centers (ASCs)
10.5. Home Care Settings
11. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
12. COMPETITIVE OVERVIEW AND KEY MARKET PLAYERS
12.1. Market Share Analysis and Positioning Matrix
12.2. Strategic Partnerships, Mergers & Acquisitions
12.3. Key Developments in Product Portfolios and Innovations
12.4. Company Benchmarking
13. COMPANY PROFILES
13.1. BD*
13.1.1. Company Overview
13.1.2. Product Portfolio
13.1.2.1. Product Description
13.1.2.2. Product Key Performance Indicators (KPIs)
13.1.2.3. Historic and Forecasted Product Sales
13.1.2.4. Product Sales Volume
14. FINANCIAL OVERVIEW
14.1. Company Revenue
14.1.1. Geographical Revenue Shares
14.1.1.1. Revenue Forecasts
14.1.2. Key Developments
14.1.2.1. Mergers & Acquisitions
14.1.2.2. Key Product Development Activities
14.1.2.3. Regulatory Approvals, etc.
14.1.3. SWOT Analysis
14.2. QuidelOrtho Corporation
14.3. QIAGEN
14.4. Trinity Biotech plc.
14.5. BioM?rieux SA
14.6. F. Hoffmann-La Roche Ltd
14.7. Siemens Healthineers AG
14.8. Abbott
14.9. Danaher Corporation
14.10. Nova Biomedical(LIST NOT EXHAUSTIVE)
15. ASSUMPTIONS AND RESEARCH METHODOLOGY
15.1. Data Collection Methods
15.2. Data Triangulation
15.3. Forecasting Techniques
15.4. Data Verification and Validation
16. APPENDIX
16.1. About Us and Services
16.2. Contact Us
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
3. MARKET HIGHLIGHTS AND STRATEGIC TAKEAWAYS
3.1. Key Trends and Future Projections
4. SNIPPET BY PRODUCT
4.1. Snippet by Technology
4.2. Snippet by Application
4.3. Snippet by End-User
5. DYNAMICS
5.1. Impacting Factors
5.1.1. Drivers
5.1.1.1. Rising Advancements in Point-of-Care Diagnostics
5.1.1.2. Rising Aging Population and Chronic Diseases in North America
5.1.1.3. XX
5.1.2. Restraints
5.1.2.1. Connectivity & Data Integration Issues
5.1.2.2. Competition from Alternative Diagnostic Technologies
5.1.2.3. XX
5.1.3. Opportunity
5.1.3.1. Expansion of Home-Based Testing
5.1.3.2. Advancements in Digital and Mobile Health Integration
5.1.4. Impact Analysis
6. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
6.1. Market Leaders and Pioneers
6.1.1. Emerging Pioneers and Prominent Players
6.1.2. Established Leaders with the Largest Marketing Brand
6.1.3. Market Leaders with Established Products
6.2. Latest Developments and Breakthroughs
6.3. North America Regulatory and Reimbursement Landscape
6.4. Porter’s Five Forces Analysis
6.5. Supply Chain Analysis
6.6. Patent Analysis
6.7. SWOT Analysis
6.8. Unmet Needs and Gaps
6.9. Recommended Strategies for Market Entry and Expansion
6.10. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
6.11. Pricing Analysis and Price Dynamics
7. POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
7.1.2. Market Attractiveness Index, By Product
7.2. Infectious Disease Testing Products*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Blood Glucose Products
7.4. Blood Gas & Electrolyte Products
7.5. Hematology Testing Products
7.6. Urinalysis Products
7.7. Pregnancy and Fertility Testing Products
7.8. Tumor/Cancer Profiling Products
7.9. Drug-of-Abuse Products
7.10. Others
8. POINT-OF-CARE DIAGNOSTICS MARKET, BY TECHNOLOGY
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
8.1.2. Market Attractiveness Index, By Technology
8.2. Lateral Flow Assays*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Immunoassays
8.4. Molecular Diagnostics
8.5. Microfluidics
8.6. Others
9. POINT-OF-CARE DIAGNOSTICS MARKET, BY APPLICATION
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Infectious Diseases*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Hematology
9.4. Cardiology
9.5. Endocrinology
9.6. Oncology
9.7. Drug Testing
9.8. Neurology
9.9. Others
10. POINT-OF-CARE DIAGNOSTICS MARKET, BY END-USER
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals & Clinics*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Diagnostic Laboratories
10.4. Ambulatory Surgery Centers (ASCs)
10.5. Home Care Settings
11. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
12. COMPETITIVE OVERVIEW AND KEY MARKET PLAYERS
12.1. Market Share Analysis and Positioning Matrix
12.2. Strategic Partnerships, Mergers & Acquisitions
12.3. Key Developments in Product Portfolios and Innovations
12.4. Company Benchmarking
13. COMPANY PROFILES
13.1. BD*
13.1.1. Company Overview
13.1.2. Product Portfolio
13.1.2.1. Product Description
13.1.2.2. Product Key Performance Indicators (KPIs)
13.1.2.3. Historic and Forecasted Product Sales
13.1.2.4. Product Sales Volume
14. FINANCIAL OVERVIEW
14.1. Company Revenue
14.1.1. Geographical Revenue Shares
14.1.1.1. Revenue Forecasts
14.1.2. Key Developments
14.1.2.1. Mergers & Acquisitions
14.1.2.2. Key Product Development Activities
14.1.2.3. Regulatory Approvals, etc.
14.1.3. SWOT Analysis
14.2. QuidelOrtho Corporation
14.3. QIAGEN
14.4. Trinity Biotech plc.
14.5. BioM?rieux SA
14.6. F. Hoffmann-La Roche Ltd
14.7. Siemens Healthineers AG
14.8. Abbott
14.9. Danaher Corporation
14.10. Nova Biomedical(LIST NOT EXHAUSTIVE)
15. ASSUMPTIONS AND RESEARCH METHODOLOGY
15.1. Data Collection Methods
15.2. Data Triangulation
15.3. Forecasting Techniques
15.4. Data Verification and Validation
16. APPENDIX
16.1. About Us and Services
16.2. Contact Us
